| Katrina L Carter, LICSW, LCSW-C | |
|
2409 Cool Spring Rd, Adelphi, MD 20783-2254 | |
| (202) 419-9020 | |
| Not Available |
| Full Name | Katrina L Carter |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 2409 Cool Spring Rd, Adelphi, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871743419 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | LC3000826 (District Of Columbia) | Secondary |
| 1041C0700X | Social Worker - Clinical | 13225 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Katrina L Carter, LICSW, LCSW-C 2409 Cool Spring Rd, Adelphi, MD 20783-2254 Ph: (202) 419-9020 | Katrina L Carter, LICSW, LCSW-C 2409 Cool Spring Rd, Adelphi, MD 20783-2254 Ph: (202) 419-9020 |
News Archive
The UCLA Health System has launched the UCLA Face Transplantation Program, the first surgical program of its kind in the western United States and one of only a handful in the nation.
In a pair of firsts, researchers at Case Western Reserve University and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more effective than an approved drug in vivo, and that a plant-virus-based carrier successfully delivers a drug in vivo.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD), announced today that results from the Phase III EINSTEIN-Extension (EXT) clinical trial of the novel oral anticoagulant rivaroxaban showed a significant reduction in the risk of recurrent symptomatic venous thromboembolism (VTE), compared to placebo, in patients who have been treated for a previous deep vein thrombosis (DVT) or pulmonary embolism (PE).
BioInformatics LLC has announced the release of their latest report, The Market for Cell-Based Assays.
Merck & Co., Inc. today announced financial results for the third quarter of 2009. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the quarter of $0.90, which excludes a $1.7 billion after-tax gain from the sale of the company's interest in Merial Limited as well as restructuring charges and pre-closing merger-related expenses. Third-quarter GAAP EPS was $1.61.
› Verified 4 days ago
Mrs. Eyvette Marie Weaver-pauling, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10302 Glenmore Dr, Adelphi, MD 20783 Phone: 301-431-0504 | |
Robin L. Semas, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3403 Notre Dame St, Adelphi, MD 20783 Phone: 301-422-2859 | |
Ms. Denise Mary Montero, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 10415 Edgefield Dr, Adelphi, MD 20783 Phone: 301-445-4734 Fax: 301-445-4739 | |
Christa Martinez, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9200 Edwards Way Apt 915, Adelphi, MD 20783 Phone: 316-993-5483 Fax: 405-286-1730 | |
Karen Shennette, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2517 Hughes Rd, Adelphi, MD 20783 Phone: 240-472-4689 | |
Mrs. Mary R Huber, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8303 Cool Spring Ln, Adelphi, MD 20783 Phone: 734-846-5772 |